About Biocon Canmab Trastuzumab 440 Mg Injection
Biocon Canmab Trastuzumab 440 Mg Injection is a top, in-demand antineoplastic solution reserved for treating HER2-positive breast and gastric cancers in adults. This peerless, hospital-use vial offers a valiant response in oncology, delivering a remarkable, monoclonal antibody-based therapy that is widely respected within the medical field. Each single-use vial contains 440 mg of Trastuzumab as a lyophilized powder, intended for intravenous reconstitution. Manufactured by Biocon in India, Canmab 440 is prescription-only and must be stored at 2-8C. The injection requires precise reconstitution, incorporates included diluent, and is specifically developed for patients seeking advanced therapeutic outcomes.
Peerless Solution for HER2-Positive Cancer
Biocon Canmab Trastuzumab 440 Mg Injection is a hospital-exclusive, prescription-only therapy designed for adult patients with HER2-positive breast or gastric cancers. Administered through IV infusion, it ensures targeted intervention using Trastuzumab-a monoclonal antibody with a valiant reputation in oncology. The product is provided in a single-use vial containing 440 mg, complemented by an included diluent, catering to precise and controlled treatments. Store between 2-8C to maintain optimal efficacy.
Certifications, Domestic Reach & Reliable Supply
Biocon Canmab Trastuzumab is shipped throughout India's main domestic market, with stringent certifications supporting its quality. Order processing is streamlined, and charges are transparent for every purchase. With robust supply ability, Biocon ensures that hospitals and healthcare centers receive prompt deliveries, strengthening cancer care capabilities nationwide. Each order reflects the manufacturer's commitment to reliability and compliance in medical supply chains.
FAQ's of Biocon Canmab Trastuzumab 440 Mg Injection:
Q: How do I use Biocon Canmab Trastuzumab 440 Mg Injection?
A: This injection is for intravenous use only and must be reconstituted and diluted as per the provided instructions before being administered by qualified healthcare professionals.
Q: What specific cancers is Canmab 440 indicated for?
A: Canmab 440 is intended for adult patients diagnosed with HER2-positive breast or gastric cancers, where targeted therapy with Trastuzumab offers significant clinical benefit.
Q: Where should Biocon Canmab Trastuzumab Injection be stored?
A: Store the vial at 2-8C in a hospital pharmacy. Do not freeze the product, as this may affect its stability and efficacy.
Q: When is reconstitution required for Canmab 440?
A: Reconstitution is required immediately before administration. The included diluent should be used to prepare the injection under sterile conditions.
Q: What are the main features of this injection?
A: The injection features a single-use vial format, contains 440 mg of Trastuzumab, and offers a shelf life of 36 months. It is odorless, white to pale yellow, and intended exclusively for hospital use.
Q: How long does order processing and shipping take within India?
A: Biocon strives for prompt charge processing and reliable delivery timelines throughout its domestic supply network, minimizing wait times for hospitals and healthcare providers.